MX368034B - Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal. - Google Patents

Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.

Info

Publication number
MX368034B
MX368034B MX2014013684A MX2014013684A MX368034B MX 368034 B MX368034 B MX 368034B MX 2014013684 A MX2014013684 A MX 2014013684A MX 2014013684 A MX2014013684 A MX 2014013684A MX 368034 B MX368034 B MX 368034B
Authority
MX
Mexico
Prior art keywords
onset
colorectal cancer
screening
gene marker
marker panel
Prior art date
Application number
MX2014013684A
Other languages
English (en)
Spanish (es)
Other versions
MX2014013684A (es
Inventor
Molloy Peter
Lapointe Lawrence
Pedersen Susanne
Original Assignee
Clinical Genomics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Genomics Pty Ltd filed Critical Clinical Genomics Pty Ltd
Publication of MX2014013684A publication Critical patent/MX2014013684A/es
Publication of MX368034B publication Critical patent/MX368034B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2014013684A 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal. MX368034B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261646174P 2012-05-11 2012-05-11
PCT/AU2013/000481 WO2013166558A1 (en) 2012-05-11 2013-05-10 Diagnostic gene marker panel for colorectal cancer

Publications (2)

Publication Number Publication Date
MX2014013684A MX2014013684A (es) 2015-06-10
MX368034B true MX368034B (es) 2019-09-17

Family

ID=49549996

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014013684A MX368034B (es) 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.
MX2019010935A MX2019010935A (es) 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019010935A MX2019010935A (es) 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Country Status (14)

Country Link
US (2) US11254985B2 (cg-RX-API-DMAC10.html)
EP (3) EP3594366B1 (cg-RX-API-DMAC10.html)
JP (3) JP6742726B2 (cg-RX-API-DMAC10.html)
CN (1) CN104411835B (cg-RX-API-DMAC10.html)
AU (3) AU2013258880B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014028122B1 (cg-RX-API-DMAC10.html)
CA (3) CA2872867C (cg-RX-API-DMAC10.html)
DK (3) DK3594366T3 (cg-RX-API-DMAC10.html)
ES (1) ES2749514T3 (cg-RX-API-DMAC10.html)
IL (1) IL235411A0 (cg-RX-API-DMAC10.html)
MX (2) MX368034B (cg-RX-API-DMAC10.html)
NZ (1) NZ701527A (cg-RX-API-DMAC10.html)
WO (1) WO2013166558A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201408120B (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024427B (zh) * 2011-08-25 2018-01-02 临床基因组学私人有限公司 结直肠和乳腺癌诊断方法中的dna甲基化
CA2872867C (en) * 2012-05-11 2020-09-15 Clinical Genomics Pty Ltd Diagnostic gene marker panel for colorectal cancer
AU2015271697B2 (en) 2014-06-04 2021-11-04 Clinical Genomics Pty Ltd Methylated markers for colorectal cancer
KR20170012552A (ko) * 2014-06-05 2017-02-02 클리니칼 게노믹스 피티와이. 엘티디. 메틸화 분석 방법
WO2016201365A2 (en) * 2015-06-12 2016-12-15 Visani Giuseppe Methods for treating cancers
GB201612815D0 (en) * 2016-07-25 2016-09-07 Belgian Volition Sa Novel combination test
KR102601593B1 (ko) 2017-04-19 2023-11-13 싱글레라 제노믹스, 인코포레이티드 라이브러리 제작 및 서열 분석을 위한 조성물 및 방법
CN109371138B (zh) * 2018-12-29 2022-10-25 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep4
AU2019200359A1 (en) * 2019-01-18 2020-09-10 Clinical Genomics Pty Ltd Screening method
JP7801235B2 (ja) * 2020-03-20 2026-01-16 シングレラ・ヘルス・テクノロジーズ(シャンハイ)・リミテッド 結腸直腸新生物をスクリーニングするための方法およびキット
KR102909106B1 (ko) * 2020-08-20 2026-01-07 에스티팜 주식회사 피롤로피리딘 유도체 및 이들의 용도
CN115927607B (zh) * 2021-08-17 2024-06-07 武汉艾米森生命科技有限公司 生物标志物在胃癌诊断中的应用
CN118679269B (zh) * 2024-04-08 2026-02-27 嘉兴允英医学检验有限公司 作为膀胱癌标志物的dna甲基化位点组合及其应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JPH02289917A (ja) 1990-04-25 1990-11-29 Sony Corp 回転ヘッドドラム装置
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
DE69739357D1 (de) 1996-06-04 2009-05-28 Univ Utah Res Found Überwachung der hybridisierung während pcr
AU7164998A (en) 1997-04-28 1998-11-24 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
EP2325335A3 (en) 2001-09-14 2012-01-25 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
JP4384603B2 (ja) 2002-06-26 2009-12-16 コールド スプリング ハーバー ラボラトリー メチル化プロファイルを測定するための方法および組成物
JP3711984B2 (ja) 2003-02-14 2005-11-02 日産自動車株式会社 ハイブリッド車両の制御装置
JP4453297B2 (ja) 2003-05-27 2010-04-21 トヨタ自動車株式会社 車両用遊星歯車式多段変速機
EP1689887B1 (en) 2003-10-21 2012-03-21 Orion Genomics, LLC Methods for quantitative determination of methylation density in a dna locus
WO2005085477A1 (en) 2004-03-02 2005-09-15 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
DE602007011237D1 (de) 2006-03-28 2011-01-27 Commw Scient Ind Res Org Amplifikation von dna-fragmenten
EP2024509A4 (en) 2006-05-22 2010-08-04 Clinical Genomics Pty Ltd DETECTION METHOD
US20090170083A1 (en) * 2007-02-02 2009-07-02 Orion Genomics Llc Gene methylation in diagnosis of melanoma
WO2008100913A2 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
AU2008307153B2 (en) 2007-10-04 2015-03-12 Commonwealth Scientific And Industrial Research Organisation Nucleic acid amplification
EP2215261B1 (en) 2007-10-23 2018-02-21 Clinical Genomics Pty Ltd A method of diagnosing neoplasms
AU2008316313B2 (en) 2007-10-23 2015-04-16 Clinical Genomics Pty. Ltd. A method of diagnosing neoplasms - II
WO2010089538A2 (en) * 2009-02-03 2010-08-12 Oncomethylome Sciences Sa Methods of detecting colorectal cancer
WO2010135786A1 (en) 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
WO2011057354A1 (en) 2009-11-13 2011-05-19 Commonwealth Scientific And Industrial Research Organisation Epigenetic analysis
US20130012410A1 (en) * 2010-03-29 2013-01-10 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal cancer and adenoma
EP2388336A1 (en) 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
CA3102758C (en) * 2010-09-13 2023-09-05 Clinical Genomics Pty. Ltd. Epigenetic markers of colorectal cancers and diagnostic methods using the same
US10041948B2 (en) * 2010-10-12 2018-08-07 Mayo Foundation For Medical Education And Research Materials and methods for determining cancer risk
WO2012054975A1 (en) 2010-10-28 2012-05-03 Clinical Genomics Pty. Ltd. Method of microvesicle enrichment
US20140155280A1 (en) 2011-05-05 2014-06-05 Commonwealth Scientific And Industrial Research Organisation Method of diagnosing neoplasms
CN104024427B (zh) 2011-08-25 2018-01-02 临床基因组学私人有限公司 结直肠和乳腺癌诊断方法中的dna甲基化
CA2872867C (en) * 2012-05-11 2020-09-15 Clinical Genomics Pty Ltd Diagnostic gene marker panel for colorectal cancer
EP2850212B1 (en) * 2012-05-18 2020-01-01 Clinical Genomics Pty. Ltd. A method of screening for colorectal cancer
EP2922973B1 (en) * 2012-11-26 2019-03-20 Clinical Genomics Pty Ltd A method of detecting methylation
AU2015271697B2 (en) * 2014-06-04 2021-11-04 Clinical Genomics Pty Ltd Methylated markers for colorectal cancer

Also Published As

Publication number Publication date
ES2749514T3 (es) 2020-03-20
EP2847355A4 (en) 2016-05-25
JP6975807B2 (ja) 2021-12-01
AU2019201294B2 (en) 2021-08-19
EP3594366B1 (en) 2021-06-23
MX2019010935A (es) 2019-10-24
US11254985B2 (en) 2022-02-22
DK3594366T3 (da) 2021-09-13
DK2847355T3 (da) 2019-10-14
JP2020089378A (ja) 2020-06-11
AU2013258880A1 (en) 2014-11-20
CA2872867C (en) 2020-09-15
BR112014028122B1 (pt) 2022-08-23
IL235411A0 (en) 2014-12-31
NZ701527A (en) 2016-07-29
US20150141275A1 (en) 2015-05-21
JP2018198600A (ja) 2018-12-20
JP2015515862A (ja) 2015-06-04
AU2013258880B2 (en) 2019-02-14
MX2014013684A (es) 2015-06-10
US20220213559A1 (en) 2022-07-07
EP4001436B1 (en) 2024-03-13
CA2872867A1 (en) 2013-11-14
EP4001436A1 (en) 2022-05-25
AU2021265861A1 (en) 2021-12-02
WO2013166558A8 (en) 2014-12-11
CA3083314A1 (en) 2013-11-14
EP2847355B1 (en) 2019-07-10
DK4001436T3 (da) 2024-05-27
BR112014028122A2 (cg-RX-API-DMAC10.html) 2017-08-15
CA3152533C (en) 2023-10-17
CA3152533A1 (en) 2013-11-14
WO2013166558A1 (en) 2013-11-14
JP6742726B2 (ja) 2020-08-19
AU2021265861B2 (en) 2024-10-10
CA3083314C (en) 2023-01-31
JP6837458B2 (ja) 2021-03-03
EP2847355A1 (en) 2015-03-18
EP3594366A1 (en) 2020-01-15
AU2019201294A1 (en) 2019-03-14
ZA201408120B (en) 2019-11-27
CN104411835B (zh) 2019-12-20
CN104411835A (zh) 2015-03-11
HK1208058A1 (en) 2016-02-19

Similar Documents

Publication Publication Date Title
MX2019010935A (es) Panel de marcadores geneticos para el diagnostico de cancer colorrectal.
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
HK1246828A1 (zh) 用於检测癌症的生物标志物组
EP2864915B8 (en) Systems and methods relating to network-based biomarker signatures
EP2811869A4 (en) DECORATIVE DETECTABLE WARNING PLATE WITH IMPROVED HANDLE
MY184733A (en) Pyrimidine fgfr4 inhibitors
EP2852839A4 (en) INTERROGATORY CELL-BASED TESTS FOR IDENTIFYING MARKERS FOR DRUG-INDICATED TOXICITY
PH12014500063A1 (en) Methods and nucleic acids for determining the prognosis of a cancer subject
WO2013106747A3 (en) Methods and compositions for the treatment and diagnosis of thyroid cancer
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
GB201121603D0 (en) ASEP+D Method:identifying anomalous areas of the earths lower crust
IN2014CN04050A (cg-RX-API-DMAC10.html)
MX2015007518A (es) Metodos para tratar el prurito.
EP3385717A3 (en) Methods of detecting prostate cancer
AU339590S (en) Radio
EP2691396A4 (en) ENOPEPTINES, USES THEREOF AND SYNTHESIS METHOD THEREFOR
EP3012634A4 (en) Biomarker for rheumatoid arthritis diagnosis or activity evaluation
EP3078765A4 (en) Hot-dip zn-alloy-plated steel sheet
BR112014028357A2 (pt) célula eletrolítica para produção de metais de terras raras.
EP2855705A4 (en) CANCER DIAGNOSIS METHOD WITH DETECTION OF THE METHYLATION SIGNATURE IN THE HTERT PROMOTER
BR112013026604A2 (pt) disposição de intertravamento de painel
EP3008202A4 (en) Methods for detecting the presence of microbes
IN2014DN08312A (cg-RX-API-DMAC10.html)
IN2012DE00794A (cg-RX-API-DMAC10.html)
WO2013040358A3 (en) Assays and compositions for detection of agr2

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration